Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study of LynxDx's Ongoing Determination of Clinical Utility of MyProstateScore 2.0 Test: A Combined CPV-Based, Patient-Level Assessment

NCT05910697 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT05910697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05910697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study of LynxDx's Ongoing Determination of Clinical Utility of MyProstateScore 2.0 Test: A Combined CPV-Based, Patient-Level Assessment
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2023
Completion date
October 18, 2023
Enrollment
142 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer